| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 06/05/2002 | EP1210724A1 Method of determining etch endpoint using principal components analysis of optical emission spectra |
| 06/05/2002 | EP1210463A2 Polymorphisms in the human cyp3a4 and cyp3a7 genes and their use in diagnostic and therapeutic applications |
| 06/05/2002 | EP1210462A2 Polymorphisms in the human hpxr gene and their use in diagnostic and therapeutic applications |
| 06/05/2002 | EP1210455A1 Novel glycosyl sulfotransferases gst-4 alpha, gst-4 beta, and gst-6 |
| 06/05/2002 | EP1210448A1 Recombinant hsv-1 and live viral vaccines |
| 06/05/2002 | EP1210445A2 Recombinant microorganisms |
| 06/05/2002 | EP1210438A2 Ehrlichia canis genes and vaccines |
| 06/05/2002 | EP1210435A1 Fhm, A NOVEL MEMBER OF THE TNF LIGAND SUPERGENE FAMILY |
| 06/05/2002 | EP1210434A2 Mammalian interleukin-12 p40 and interleukin b30. combinations thereof. antibodies. uses in pharmaceutical compositions |
| 06/05/2002 | EP1210430A2 Muc-1 derived peptides |
| 06/05/2002 | EP1210429A2 Apoptosis proteins |
| 06/05/2002 | EP1210428A1 Pd-1, a receptor for b7-4, and uses therefor |
| 06/05/2002 | EP1210425A2 Baff receptor (bcma), an immunoregulatory agent |
| 06/05/2002 | EP1210424A1 Novel b7-4 molecules and uses therefor |
| 06/05/2002 | EP1210410A2 Metal binding compounds and their use in cell culture medium compositions |
| 06/05/2002 | EP1210374A1 Human monoclonal antibodies to prostate specific membrane antigen |
| 06/05/2002 | EP1210373A2 Congener independent detection of microcystin and nodularin congeners |
| 06/05/2002 | EP1210372A2 Human monoclonal antibodies to her2/neu |
| 06/05/2002 | EP1210366A1 Homologs of a pneumococcal protein and fragments for vaccines |
| 06/05/2002 | EP1210364A1 Vaccine antigens of moraxella |
| 06/05/2002 | EP1210362A2 Identification of peptides that facilitate uptake and cytoplasmic and/or nuclear transport of proteins, dna and viruses |
| 06/05/2002 | EP1210355A2 Glycoconjugates, glycoamino, acids, intermediates thereto, and uses thereof |
| 06/05/2002 | EP1210115A1 DOSAGES FOR TREATMENT WITH ANTI-ErbB2 ANTIBODIES |
| 06/05/2002 | EP1210114A1 Outer membrane protein a, peptidoglycan-associated lipoprotein, and murein lipoprotein as therapeutic targets for treatment of sepsis |
| 06/05/2002 | EP1210113A2 Combined vaccine compositions |
| 06/05/2002 | EP1210112A2 Vaccine against hbv and hpv |
| 06/05/2002 | EP1210111A1 Gamma-herpesvirus dna and methods of use |
| 06/05/2002 | EP1210109A2 Utilization of an aminopeptidase inhibitor |
| 06/05/2002 | EP1109817B1 Phosphohalohydrins, method for making same and uses |
| 06/05/2002 | EP0894008B1 Method of producing immunogenic products and vaccines |
| 06/05/2002 | EP0815134B1 Modulators of amyloid aggregation |
| 06/05/2002 | EP0752870B1 Use of mycobacterium for the treatment of tumours |
| 06/05/2002 | EP0746398B1 Antibody purification |
| 06/05/2002 | CN1352691A Human complement C3-degrading polypeptide from i(streptococcus pneumoniae) |
| 06/05/2002 | CN1352686A Cytokine receptor chain |
| 06/05/2002 | CN1352683A Compositions and methods for the treatment and diagnosis of breast cancer |
| 06/05/2002 | CN1352682A Cysteine protease and inhibitors for prevention and treatment of neurocysticerocosis |
| 06/05/2002 | CN1352651A Method for inhibiting macrophage infiltration using monoconal anti-alpha-D-antibodies |
| 06/05/2002 | CN1352650A Recombinant IL-18 antagonist useful in treatment of IL-18 mediated disorders |
| 06/05/2002 | CN1352649A Peptides from the TT virus sequence and monospecific antibodies binding to the TT virus |
| 06/05/2002 | CN1352562A Copper agonist that binds on the copper binding site of APP and/or exerts an inhibiting effect on the release of anyloid A beta peptide |
| 06/05/2002 | CN1352391A Novel anti-tumor medicine and its screening method and use |
| 06/05/2002 | CN1351888A Method for producing anti-osteopontic antibody medicine and use |
| 06/04/2002 | US6399764 DNA molecule encoding for cellular uptake of mycobacterium tuberculosis and uses thereof |
| 06/04/2002 | US6399571 Polypeptides |
| 06/04/2002 | US6399385 Conjugating a genetically engineered virus with polyethylene glycol at ambient temperature for improved gene expression |
| 06/04/2002 | US6399372 Monocyte derived cells with immunostimulating properties, their preparation and uses |
| 06/04/2002 | US6399362 Includes biological source material such as nucleic acids and a dispensing device for spray of dispersed particles |
| 06/04/2002 | US6399353 Biosynthesizing human papillomavirus in epithelial cell containing viral dna but not particles by activating cell differentiation by exposing to protein kinase c inducer; drug screening of viricides |
| 06/04/2002 | US6399343 Amino acid sequence of gene from streptococcus; drug screening for bactericides |
| 06/04/2002 | US6399328 Amino acid sequence; hybridization probes; amplification primers; anticarcinogenic agents; antitumor agents |
| 06/04/2002 | US6399326 Nucleic acid which encodes polypeptide of defined amino acid sequence which has a cysteine motif |
| 06/04/2002 | US6399294 Probes; primers; immunogens; for diagnosis of human immunodeficiency virus infections |
| 06/04/2002 | US6399077 Administering to an animal a toxoplasma gondii soluble parasite antigen and interleukin-15 |
| 06/04/2002 | US6399076 Acellular pertussis vaccines and methods of preparation thereof |
| 06/04/2002 | US6399074 Live attenuated salmonella vaccines to control avian pathogens |
| 06/04/2002 | US6399071 Removal of xenobodies from body fluid |
| 06/04/2002 | US6399070 Heat shock protein complex for immunology |
| 06/04/2002 | US6399069 Purification and prevention of disease with heat shock protein bound to antigens |
| 06/04/2002 | US6399068 Cancer treatment, interleukins, fusion proteins, cell markers |
| 06/04/2002 | US6399067 Methods and compositions for impairing multiplication of HIV-1 |
| 06/04/2002 | US6399066 Capsular polysaccharide adhesin antigen, preparation, purification and use |
| 06/04/2002 | US6399065 Methods for modulating SLAM-expressing T cells |
| 06/04/2002 | US6399063 Monoclonal antibodies directed to the HER2 receptor |
| 06/04/2002 | US6399061 Monoclonal secreted by atcc deposit no. hb11388 and transfectoma tcae8 accorded atcc deposit no. 69119; parenteral injection |
| 06/04/2002 | US6399054 Mhc restricted, tumor-specific t cells; incubating with ternary complex of biotinylated antibody against cell surface antigen, an avidin, streptavidin or neutravidin ligand, and biotinylated b7-ig, co-cultivating tumor cells with t cells |
| 06/04/2002 | CA2078990C Phospholipid-coated microcrystals: injectable formulations of water-insoluble drugs |
| 06/04/2002 | CA1341364C Single polypeptide chain binding molecules |
| 06/01/2002 | CA2325666A1 Immunogenic mutated peptides derived from r9m, polynucleotides, coding polynucleotides and their therapeutic uses |
| 05/30/2002 | WO2002042776A2 Compositions and methods relating to prostate specific genes and proteins |
| 05/30/2002 | WO2002042772A1 TRIPEPTIDE OF FCηRIIA |
| 05/30/2002 | WO2002042480A2 Modified vaccinia ankara virus variant |
| 05/30/2002 | WO2002042460A2 Compositions and methods relating to colon specific genes and proteins |
| 05/30/2002 | WO2002042456A2 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 05/30/2002 | WO2002042455A2 Modifier of organelle metalbolism |
| 05/30/2002 | WO2002042432A2 Epothilone resistant cell lines |
| 05/30/2002 | WO2002042335A1 Polysaccharide compound having immune stimulating activity |
| 05/30/2002 | WO2002042332A2 Truncated cd200 |
| 05/30/2002 | WO2002042329A2 Compositions and methods relating to prostate specific genes and proteins |
| 05/30/2002 | WO2002042325A2 Cyp1b1 nucleic acids and methods of use |
| 05/30/2002 | WO2002042317A2 Method of separating extra-chromosomal dna from other cellular components |
| 05/30/2002 | WO2002042292A2 Indol derivative and their use as inhibitors of p38 kinase |
| 05/30/2002 | WO2002041921A2 Compositions for protection against bovine viral diseases |
| 05/30/2002 | WO2002041914A1 Method for treating neoplasia by administering an anti-her2 antibody and a cgmp-specific phosphodiesterase inhibitor |
| 05/30/2002 | WO2002041913A1 Collectins as adjuvants |
| 05/30/2002 | WO2002041763A2 Compositions and methods for the therapy and diagnosis of colon cancer |
| 05/30/2002 | WO2002028440B1 Methods and compositions for modulating t cell activation and uses thereof |
| 05/30/2002 | WO2002028423A8 Stabilisation of plasmid inheritance in bacteria by preventing multimerisation |
| 05/30/2002 | WO2002022782A3 Homologous 28-kilodalton immunodominant protein genes of ehrlichia canis and uses thereof |
| 05/30/2002 | WO2002022679A3 Variants of phleum pratense allergenic proteins |
| 05/30/2002 | WO2002022648A3 Compositions and methods for inducing specific cytolytic t cell responses |
| 05/30/2002 | WO2002020736A9 Proteases |
| 05/30/2002 | WO2002013844A3 Specific autoimmune reactions against isomerised/optically inverted epitopes: application for treatment of autoimmune diseases |
| 05/30/2002 | WO2002009643A3 Vaccines for broad spectrum protection against diseases caused by neisseria meningitidis |
| 05/30/2002 | WO2002008426A3 Fh-binding protein of streptococcus pneumoniae |
| 05/30/2002 | WO2001097841A3 Qs-21 and il-12 as an adjuvant combination |
| 05/30/2002 | WO2001095928A3 Methods for regulating a cell-mediated immune response by blocking lymphocytic signals and by blocking lfa-1 mediated adhesion |
| 05/30/2002 | WO2001091789A3 Combination of a mutant herpes virus and a chemotherapeutic agent for the treatment of cancer |
| 05/30/2002 | WO2001087979A3 Methods and compositions of matter concerning april/g70, bcma, blys/agp-3, and taci |
| 05/30/2002 | WO2001087330A3 Compositions and methods for achieving immune suppression |